Gain‐of‐function mutations in NLRC4 cause potentially lethal periodic fever syndromes that are characterized by high circulating IL‐18 levels and increased risk for the development of macrophage activation syndrome (MAS).65, 66. Here, IL18 is linked to macrophage activation syndrome.